Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| NCI-2023-00638 | Registry Identifier | CTRP (Clinical Trials Reporting Program) |
Not provided
Not provided
Not provided
slow accrual; investigator retired
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To compare radiation dermatitis severity in irradiated skin protected by an agent verses uncovered skin based on photographs and track patient reported outcomes with use of the agent.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group 1- StrataXRT |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| StrataXRT | Drug | Patients will be asked to start topical application of their allocated topical preparation on the area of skin that will be irradiated at the onset of radiation therapy, every day until skin symptoms subside (see patient information pamphlet). Apply twice per day and can be reapplied as skin symptoms arise or as needed. The amount of StrataXRT provided to each patient will be recorded throughout treatment. |
| Measure | Description | Time Frame |
|---|---|---|
| To compare radiation dermatitis severity in irradiated skin protected by an agent versus uncovered skin (internal control) based on photographs. | First day of treatment and last day of radiation therapy (approximately 6 weeks, but will vary per patient) +/- 4 days |
| Measure | Description | Time Frame |
|---|---|---|
| Patient reported outcomes | Patients will be asked to complete a survey at the end of study that will ask them to provide feedback on the agent used during their treatment. | Upon study completion, on average 6 weeks, but will vary per patient |
Not provided
Inclusion Criteria:
Note: patients undergoing concurrent chemotherapy are eligible.
Exclusion Criteria:
Not provided
Not provided
Not provided
Adults with head and neck cancer
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ivy Petersen, MD | Mayo Clinic Radiation Oncology | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | United States |
Not provided
| Label | URL |
|---|---|
| Mayo Clinic Clinical Trials | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D011855 | Radiodermatitis |
| ID | Term |
|---|---|
| D003872 | Dermatitis |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D011832 | Radiation Injuries |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| D014947 |
| Wounds and Injuries |